Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN13471603
ISRCTN13471603
Completed
未知

Management of patients with heart failure with preserved ejection fraction: what do patients and providers need and want? A qualitative and survey-based study

Cambridge University Hospitals NHS Foundation Trust0 sites50 target enrollmentJune 17, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHeart failure with preserved ejection fraction, impact of COVID-19 (SARS-CoV-2 infection) pandemic on healthcare received and providedCirculatory SystemHeart failure

Overview

Phase
未知
Intervention
Not specified
Conditions
Heart failure with preserved ejection fraction, impact of COVID-19 (SARS-CoV-2 infection) pandemic on healthcare received and provided
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Enrollment
50
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33139334/ (added 18/05/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33401942/ (added 18/05/2021) 2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31772040/ (added 05/10/2022)

Registry
who.int
Start Date
June 17, 2020
End Date
November 1, 2020
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •This is a recall study: patients, carers and healthcare professionals who participated in OPTIMISE HFpEF (https://clinicaltrials.gov/ct2/show/NCT03617848\) and provided 'consent to be contacted' will be invited to participate

Exclusion Criteria

  • •Does not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Ghana heart failure registryHeart failureCirculatory System
ISRCTN18216214Deutsche Gesellschaft für Internationale Zusammenarbeit5,000
Active, not recruiting
Phase 1
Management of the patient with heart failure and diabetes: may insulin be a problem?Heart failure and diabetesMedDRA version: 21.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.1Level: LLTClassification code 10007555Term: Cardiac failure (NOS)System Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2018-001057-26-ITIRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI142
Completed
Phase 4
Therapy optimalisation of heart failure in primairy care Utrecht (TOPHU)heart failure10019280
NL-OMON35310niversitair Medisch Centrum Utrecht700
Recruiting
Not Applicable
Therapy optimalisation of heart failure in primary care Utrecht.Heart failure, therapy, beta-blocker, quality of live
NL-OMON28254one730
Unknown
Phase 2
Evaluation of a Primary Care Based Heart Failure Management ProgramHeart Failure
NCT00182182Hamilton Health Sciences Corporation170